CIK 0001196298
- Non-accelerated filer
- Smaller reporting company
NEPHROS INC
Sign in to watch- Ticker
- NEPH
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 133971809
- Phone
- +1 201-343-5202
- Business address
- 380 LACKAWANNA PLACE, SOUTH ORANGE, NJ, 07079
- Open-market buys, last 90 days
- $22,075
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$22,075. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 89 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-12-20 | Pinto Moshe Director | Grant or award | +73,864 | 156,445 | ||
| 2017-12-20 | Pinto Moshe Director | Grant or award · Stock Option (Right to Buy) | +40,284 | 40,284 | ||
| 2017-12-20 | AMRON ARTHUR H Director | Grant or award | +73,864 | 73,864 | ||
| 2017-12-20 | AMRON ARTHUR H Director | Grant or award · Non-Qualified Stock Option | +40,284 | 40,284 | ||
| 2017-12-20 | Mieyal Paul A Director | Grant or award | +73,864 | 73,864 | ||
| 2017-12-20 | Mieyal Paul A Director | Grant or award · Non-qualified stock option | +40,284 | 40,284 | ||
| 2017-12-20 | PERSEN MALCOLM C Director | Grant or award | +113,636 | 265,241 | ||
| 2017-12-20 | PERSEN MALCOLM C Director | Grant or award · Stock Option (Right to Buy) | +40,284 | 40,284 | ||
| 2017-12-20 | Pinto Moshe Director | Grant or award | +73,864 | 156,445 | ||
| 2017-12-20 | Pinto Moshe Director | Grant or award · Stock Option (Right to Buy) | +40,284 | 40,284 | ||
| 2017-12-20 | Astor Andrew Chief Financial Officer | Grant or award | +120,417 | 335,459 | ||
| 2017-12-20 | Astor Andrew Chief Financial Officer | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2017-12-20 | Evans Daron President and CEO | Grant or award | +180,000 | 892,958 | ||
| 2017-12-20 | Evans Daron President and CEO | Grant or award · Stock Option (Right to Buy) | +837,125 | 837,125 | ||
| 2017-12-04 | Astor Andrew Chief Financial Officer | Purchase | +8,333 | $0.50 | $4K | 215,042 |
| 2017-12-01 | Astor Andrew Chief Financial Officer | Purchase | +10,000 | $0.50 | $5K | 206,709 |
| 2017-09-06 | Evans Daron President and CEO | Purchase | +28,000 | $0.24 | $7K | 712,958 |
| 2017-09-05 | Evans Daron President and CEO | Purchase | +1,580 | $0.24 | $371 | 684,958 |
| 2017-08-28 | Astor Andrew Chief Financial Officer | Purchase | +6,000 | $0.27 | $2K | 192,709 |
| 2017-08-28 | Astor Andrew Chief Financial Officer | Purchase | +4,000 | $0.27 | $1K | 196,709 |
Page 10 of 16 · 312 trades